Literature DB >> 25046790

Sacroiliac joint radiofrequency ablation with a multilesion probe: a case series of 60 patients.

Peter C Schmidt1, Carlos A Pino, Kevin E Vorenkamp.   

Abstract

This retrospective case series of patients with refractory sacroiliac joint (SIJ) pain presents our first 77 SIJ radiofrequency ablation (RFA) procedures performed with a multilesion probe. Of these, 16 (20.8%) provided no relief; 55 (71.4%) provided >50% pain relief at 6 weeks; 42 (54.5%, 95% confidence interval, 42.8%-65.8%) provided >50% pain relief at 6 months; and 12 (15.6%) continued to provide >50% pain relief at 1 year. These results compare favorably to those published using other RFA techniques. In conclusion, more than half of our patients with refractory SIJ pain received some pain relief for at least 6 months after RFA.

Entities:  

Mesh:

Year:  2014        PMID: 25046790     DOI: 10.1213/ANE.0000000000000282

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Radiofrequency denervation for treatment of sacroiliac joint pain-comparison of two different ablation techniques.

Authors:  Simon Heinrich Bayerl; Tobias Finger; Petra Heiden; Nazli Esfahani-Bayerl; Christopher Topar; Vincent Prinz; Johannes Woitzik; Julius Dengler; Peter Vajkoczy
Journal:  Neurosurg Rev       Date:  2018-07-31       Impact factor: 3.042

Review 2.  Review of Opioid Sparing Interventional Pain Management Options and Techniques for Radiofrequency Ablations for Sacroiliac Joint Pain.

Authors:  Mila Pastrak; Nikola Vladicic; Jordan Sam; Bruce Vrooman; Frederick Ma; Ammar Mahmoud; James S Khan; Alaa Abd-Elsayed; Farhan Khandwalla; Scott McGilvray; Ognjen Visnjevac
Journal:  Curr Pain Headache Rep       Date:  2022-09-30

3.  Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back Pain: The Mint Randomized Clinical Trials.

Authors:  Johan N S Juch; Esther T Maas; Raymond W J G Ostelo; J George Groeneweg; Jan-Willem Kallewaard; Bart W Koes; Arianne P Verhagen; Johanna M van Dongen; Frank J P M Huygen; Maurits W van Tulder
Journal:  JAMA       Date:  2017-07-04       Impact factor: 56.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.